Volume 20 (2021)
Volume 19 (2020)
Volume 18 (2019)
Volume 17 (2018)
Volume 16 (2017)
Volume 15 (2016)
Volume 14 (2015)
Volume 13 (2014)
Volume 12 (2013)
Volume 11 (2012)
Volume 10 (2011)
Number of Volumes 12
Number of Issues 46
Number of Articles 511
Number of Contributors 1,655

- We would like to inform you about the title of our journal, which has previously been entitled "Iranian Journal of Neurology". 
- The new title is Current Journal of Neurology. The changes are effective as of  Vo. 19, No. 1.

- The Current Journal of Neurology is dedicated to the Iranian Neurological Association.

- The Journal is a peer-reviewed journal published quarterly and publishes neurological experiences in basic or clinical fields.

- The Current Journal of Neurology aims to publish manuscripts of a high scientific quality representing original clinical, diagnostic or experimental works or observations in neurological sciences. Papers in English are welcomed, particularly those which bring novel information and research in clinical or basic fields from the neurological disorders. All received manuscripts coving the scope of the journal will be evaluated by properly competent referees.

- This Journal Indexed in Scopus, PubMed, PubMed Central, ESCI (Web of Science), Academic Keys, Ebsco, Electronic Journals Library, Google Scholar, InfoBase Index, Islamic World Science Citation Center (ISC), LocatorPlus, Scientific Information Database (SID), Ulrichsweb Global Serials Directory, WorldCat.

Original Article
Adding erythropoietin to intravenous methylprednisolone in acute treatment of attacks of neuromyelitis optica spectrum disorders: A randomized controlled trial

Maryam Shafaei; Fereshteh Ghadiri; Amirreza Azimi; Abdorreza Naser Moghadasi; Mahdi Hakiminezhad; Mohammad Ali Sahraian

Volume 21, Issue 4 , October 2022, Pages 201-205

  Background: Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disease of the central nervous system (CNS) that prompts immediate potent treatment. Delaying treatment could leave debilitating sequelae. As erythropoietin (EPO) has shown neuroprotective effects, we studied the effects of adding ...  Read More

Original Article
Psychometric assessment of the Persian version of the patient determined disease steps scale in patients with multiple sclerosis and neuromyelitis optica spectrum disorder

Omid Mirmosayyeb; Vahid Shaygannejad; Mahshad Afsharzadeh; Roozbeh Bataei; Nasim Nehzat; Aida Mohammadi; Mahsa Ghajarzadeh

Volume 21, Issue 4 , October 2022, Pages 206-210

  Background: The purpose of this study was to evaluate the validity and reliability of the Persian version of Patient Determined Disease Steps (PDDS) in both patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD).Methods: One hundred and forty-five patients were enrolled ...  Read More

Original Article
The effectiveness of amantadine and dalfampridine in improving fatigue in patients with multiple sclerosis: A randomized, double-blind, clinical trial

Yasaman Sadeqi; Seyed Mohammad Baghbanian; Aliyeh Bazi; Monireh Ghazaeian; Sahar Fallah

Volume 21, Issue 4 , October 2022, Pages 211-216

  Background: Fatigue is a common complication associated with multiple sclerosis (MS). The aim of this study was to evaluate the impact of dalfampridine and amantadine on fatigue in patients with MS.Methods: This was a randomized, double-blind, clinical trial on patients with MS. The recruited patients ...  Read More

Original Article
Trend of incidence and mortality of brain and central nervous system cancer in Iran from 1990 to 2017: A global burden of disease-based study

Hedayat Abbastabar

Volume 21, Issue 4 , October 2022, Pages 217-223

  Background: Brain and central nervous system (CNS) cancers make up about 3% of all cancers around the world and are more common among men than women. Present study aimed to evaluate the occurrence trend of brain and CNS cancers in Iran from 1990 to 2017.Methods: This study using global burden of disease ...  Read More

Original Article
The effect of levetiracetam on depression and anti-oxidant activity in patients with epilepsy

Jafar Mehvari-Habibabadi; Mohammad Zare; Mohammad Reza Aghaye-Ghazvini; Maryam Rahnama

Volume 21, Issue 4 , October 2022, Pages 224-229

  Background: Levetiracetam (LEV) is approved for treating epilepsy. The current evidence shows that LEV can cause behavioral problems such as depression. It is well-known that depression is associated with oxidative stress. Therefore, we conducted this study to assess the influence of LEV on depression ...  Read More

Original Article
Assessment of COVID-19 vaccine attitude in people with multiple sclerosis, its correlation with demographic factors, and fear of coronavirus: A cross-sectional survey

Mohammad Reza Fattahi; Arad Iranmehr; Roghayyeh Saeedi; Mohammad Ali Sahraian; Rozita Doosti; Abdorreza Naser Moghadasi

Volume 21, Issue 4 , October 2022, Pages 230-235

  Background: Despite special global considerations which have been made to prioritize vaccination of people with multiple sclerosis (MS), some are reluctant to get vaccinated. This study was aimed to evaluate the attitude toward coronavirus disease-2019 (COVID-19) vaccine and its probable correlations.Methods: ...  Read More

Original Article
Association between plasma PCSK9 levels and lipid profile in patients with Parkinson’s disease and comparison with healthy subjects

Mohammad Reza Jahed; Seyed Amir Hassan Habibi; Golnaz Vaseghi; Hasan Amiri; Hamed Montazeri; Azadeh Eshraghi

Volume 21, Issue 4 , October 2022, Pages 236-243

  Background: Up to know, limited and contradictory results have been published about the role of prognostic values of lipid profile and proprotein convertase subtilisin/kexin type 9 (PCSK9) in Parkinson’s disease (PD). The aim of the present study is to investigate the role of lipid profile and ...  Read More

Review Article
Transient global amnesia after COVID-19: A systematic scoping review of case reports

Mohsen Farjoud-Kouhanjani; Mohammad Shafie’ei; Mohammad Hossein Taghrir; Zahra Akbari; Seyed Mohammad Amir Hashemi; Zahra Eghlidos; Afshin Borhani-Haghighi; Abbas Rahimi-Jaberi

Volume 21, Issue 4 , October 2022, Pages 244-250

  Background: Transient global amnesia (TGA) is a sudden-onset transient memory impairment along with intact neurologic examinations. Even though it is a benign neurologic condition with many differential diagnoses, the incidence rate of TGA is reported to have increased since the onset of the pandemic. ...  Read More

Guillain-Barre syndrome in patients with coronavirus disease-2019: Report of six cases and review of literature

Ali Asghar Okhovat; Behnaz Ansari; Helia Hemasian; Bahram Haghi-Ashtiani; Soroor Advani; Bentolhoda Ziaadini; Siamak Abdi; Hajir Sikaroudi; Shahriar Nafissi; Farzad Fatehi

Volume 19, Issue 3 , July 2020, , Pages 122-130


  Background: Few studies have reported the association of Guillain-Barre syndrome (GBS) and coronavirus disease-2019 (COVID-19) infection. In this study, we reported GBS in six patients infected with COVID-19 and reviewed all existing literature about GBS in association with COVID-19. Methods: This study ...  Read More

Assessment of computed tomography perfusion RAPID estimated core volume accuracy in patients following thrombectomy

Riwaj Bhagat; Allison Muha; Kerri Remmel; Wei Liu

Volume 21, Issue 1 , January 2022, , Pages 17-22


  Background: Computed Tomography Perfusion (CTP) maps ischemic core volume (CV) and penumbra following a stroke; however, its accuracy in early symptom onset is not well studied. We compared the accuracy of CTP RAPID estimated CV with diffusion weighted imaging (DWI) infarct volume (IV) in patients following ...  Read More

Effect of energy conservation strategies on fatigue, function, and quality of life in adults with motor neuron disease: Randomized controlled trial

Hamid Reza Fateh; Reihaneh Askary-Kachoosangy; Niloofar Shirzad; Alireza Akbarzadeh-Baghban; Farzad Fatehi

Volume 21, Issue 2 , April 2022, , Pages 83-90


  Background: Fatigue is one of the most frequent complaints in patients with motor neuron diseases (MNDs), with a significant impact on the quality of life (QOL). Current pharmacological or non-pharmacological treatments of fatigue in this population lack enough evidence to be applied in the clinical ...  Read More

A randomized controlled trial investigating the effects of a mediterranean-like diet in patients with multiple sclerosis-associated cognitive impairments and fatigue

Soodeh Razeghi-Jahromi; Rozita Doosti; Zeinab Ghorbani; Roghayyeh Saeedi; Maryam Abolhasani; Naeemeh Akbari; Fatemeh Cheraghi-Serkani; Abdorreza Naser Moghadasi; Amirreza Azimi; Mansoureh Togha; Mohammad Ali Sahraian

Volume 19, Issue 3 , July 2020, , Pages 112-121


  Background: Among multiple sclerosis (MS) related symptoms and complications, fatigue might impact roughly 90% of patients. Decline in cognitive function is one of the other complications that occur in the first years after disease onset. The Mediterranean diet is one of the well-known anti-inflammatory ...  Read More

B vitamins and their combination could reduce migraine headaches: A randomized double-blind controlled trial

Shiva Nematgorgani; Soodeh Razeghi-Jahromi; Elham Jafari; Mansoureh Togha; Pegah Rafiee; Zeinab Ghorbani; Zeynab Sadat Ahmadi; Vali Baigi

Volume 21, Issue 2 , April 2022, , Pages 105-118


  Background: The B vitamins can potentially help prevent migraine. This study was designed to examine the effects of supplementation with thiamine (B1), pyridoxine (B6), cobalamin (B12), folic acid (B9), and a combination of these vitamins on women with episodic migraine (EM).Methods: This study was a ...  Read More

Original Article
Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment

Fereshteh Ghadiri; Elnaz Asadollahzadeh; Zahra Ebadi; Mohammad Ali Sahraian; Amirreza Azimi; Samira Navardi; Hora Heidari; Zohreh Abna; Marzieh Aboutorabi; Iman Adibi; Seyed Mohammad Baghbanian; Sepideh Paybast; Maryam Poursadeghfard; Samaneh Hosseini; Sareh Shahmohammadi; Mehran Ghaffari; Hamidreza Ghalyanchi-Langroodi; Masoud Ghiasian; Hoda Kamali; Ebrahim Kouchaki; Farzad Mehrabi; Ehsan Mohammadianinejad; Mohammad Ali Nahayati; Abdorreza Naser Moghadasi

Articles in Press, Accepted Manuscript, Available Online from 16 January 2023

  Background: People with multiple sclerosis ‎(MS) and their physicians recognize cognitive retention as an important desired outcome of disease-modifying therapies (DMTs). In this study, we attempted to gather the opinions of Iranian MS experts regarding the treatment approach toward clinical ...  Read More

Original Article
Comparison of side effects of the dose-1 of AstraZeneca and Sinopharm vaccines in patients with multiple sclerosis in Kermanshah, Iran (2021)

Nazanin Razazian; Mohammad Ali Sahraian; Mansour Rezaei; Sharareh Eskandarieh; Kianoosh Khamoushian; Seyede Elham Mousavi; Negin Fakhri

Articles in Press, Accepted Manuscript, Available Online from 25 January 2023

  Background: Coronavirus 2019 (COVID-19) vaccination is recommended for people with multiple sclerosis (MS). This study evaluated the side effects of Sinopharm and AstraZeneca vaccines in MS patients.Methods: In this cross-sectional study among MS patients in Kermanshah province, Iran, who received Sinopharm ...  Read More

Original Article
Challenges of patients with multiple sclerosis in receiving health care services in Iran

Niloofar Jahromi; Sharareh Eskandarieh; Nazanin Maleki; Narges Sistany-Allahabadi; Mohammad Ali Sahraian

Articles in Press, Accepted Manuscript, Available Online from 30 January 2023

  Background: Multiple sclerosis (MS) is a debilitating, non-traumatic, neurological disorder in young adults and can reduce quality of life (QoL) by interfering with the ability to work, leisure activities, and routine living tasks. Various studies have shown the dissatisfaction of people with MS in different ...  Read More

Original Article
The effect of body mass index on the morbidity and outcomes of COVID-19 in Iranian patients with multiple sclerosis

Nasim Rezaeimanesh; Naghmeh Abbasi; Mohammad Ali Sahraian; Amirreza Azimi; Soodeh Razeghi-Jahromi; Abdorreza Naser Moghadasi

Articles in Press, Accepted Manuscript, Available Online from 01 February 2023

  Background: It seems that patients with multiple sclerosis (MS) are at a higher risk for coronavirus disease 2019 (COVID-19) implications due to being subjected to immunomodulatory or immunosuppressive treatments. Besides, obesity as a risk factor may lead to more adverse consequences. The relationship ...  Read More

Original Article
The association of serum carnitine levels with severity of fatigue in patients with multiple sclerosis: A pilot study

Mohammad Hossein Harirchian; Siavash Babaie; Nika Keshtkaran; Sama Bitarafan

Articles in Press, Accepted Manuscript, Available Online from 02 February 2023

  Background: Fatigue is a common complaint of patients with multiple sclerosis (MS), adversely affecting their quality of life. There is a lot of evidence showing that carnitine deficiency is linked to fatigue development and severity in some conditions. This study aimed to evaluate the association between ...  Read More

Original Article
Stability monitoring of patients with myasthenia gravis using a mobile-based application

Emad Alaei Tafti; Marjan Ghazisaeedi; Payam Sarraf

Articles in Press, Accepted Manuscript, Available Online from 06 February 2023

  Background: Failure in early diagnosis of myasthenia gravis (MG) and the risks of taking certain medications and undergoing surgery and anesthesia can lead to severe respiratory disorders and death. However, there are therapeutic measures that significantly control the disease and improve individual’s ...  Read More

Original Article
Association analysis of serotonin transporter gene polymorphism among the South-Indian migraineurs

Pallavi Kesavan; Aiswarya Padmaja Satheesh; Akram Husain Rehman Syed Rasheed; Umamaheshwari Veerappan; Subramaniyan Kannaian; Ramakrishnan Veerabathiran

Articles in Press, Accepted Manuscript, Available Online from 09 February 2023

  Background: Migraine is a multifactorial neurological disorder characterized by frequent moderate to severe intensity headaches. The genetic variations in synaptic and post-receptor signalling proteins have direct effect on the process of serotonergic neurotransmission.Methods: We aimed to investigate ...  Read More

Review Article
The relationship between retinal layer thickness and cognition in patients with multiple sclerosis: A systematic review of current literature

Abdorreza Naser Moghadasi; Omid Mirmosayyeb; Narges Ebrahimi; Mohammad Ali Sahraian; Aida Mohammadi; Mahsa Ghajarzadeh

Articles in Press, Accepted Manuscript, Available Online from 22 January 2023

  Background: This study was conducted to evaluate the relationship between retinal layer thickness (RLT) and cognition in patients with multiple sclerosis (MS).Methods: We searched PubMed, Scopus, Embase, Web of Science, and Google Scholar. The search strategy included the MeSH and text words as [“ora ...  Read More

Short Communication
A nomogram-based clinical tool for acute ischemic stroke screening in prehospital setting

Alireza Baratloo; Mahtab Ramezani; Hosein Rafiemanesh; Meisam Sharifi; Somayeh Karimi

Articles in Press, Accepted Manuscript, Available Online from 14 January 2023

  Background: We believe that designing a new tool which is comparable in terms of both sensitivity and specificity may play an important role in rapid and more accurate diagnosis of acute ischemic stroke (AIS) in prehospital stage. Therefore, we intended to develop a new clinical tool for the diagnosis ...  Read More

Review Article
Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review

Fereshteh Ghadiri; Omid Mirmosayyeb; Mohammad Ali Sahraian; Abdorreza Naser Moghadasi; Mahsa Ghajarzadeh

Articles in Press, Accepted Manuscript, Available Online from 13 March 2023

  Background: Fingolimod is approved in relapsing-remitting multiple sclerosis (RRMS) with the recommended dose of 0.5 mg daily. To tackle possible adverse events, some clinicians may reduce the dose of fingolimod, mainly in the alternate-day form. We systematically reviewed the literature for efficacy ...  Read More

Original Article
Fear of re-infection, relapse, and anxiety during COVID-19 pandemic in patients with multiple sclerosis: A multi-center study

Abdorreza Naser Moghadasi; Saeed Vaheb; Sara Hamtaei-Ghashti; Aysa Shaygannejad; Mozhdeh Askari; Vahid Shaygannejad; Mohmmad Ali Sahraian; Mahsa Ghajarzadeh

Articles in Press, Accepted Manuscript, Available Online from 18 March 2023

  Background: Fear of relapse and re-infection during the coronavirus disease 2019 (COVID-19) pandemic can affect people with chronic relapsing diseases, such as multiple sclerosis (MS). We evaluated fear of re-infection, anxiety, and relapse during the COVID-19 pandemic in Iranian people with MS.Methods: ...  Read More

Tehran University of Medical Sciences

Mahmood Motemedi

Shahriar Nafissi, M.D,

Deputy Editor:
Farzad Fatehi, M.D,

Editorial Board:
Shahram Attarian, M.D, P.h.D

Frequency: Quarterly

Online ISSN: 2717-011X


This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE).

iThenticate: Plagiarism Detection Software

Each manuscript published in the Current Journal of Neurology will be checked by iThenticate.

Keywords Cloud